Nektar Therapeutics
NKTR
#4531
Rank
โ‚น205.54 B
Marketcap
โ‚น7,165
Share price
1.69%
Change (1 day)
1,039.71%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : โ‚น17.73 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are โ‚น17.73 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31โ‚น17.10 B-17.97%
2024-12-31โ‚น20.85 B-6.19%
2023-12-31โ‚น22.23 B-21.89%
2022-12-31โ‚น28.46 B-12.63%
2021-12-31โ‚น32.57 B-3.47%
2020-12-31โ‚น33.74 B-17.26%
2019-12-31โ‚น40.78 B34.84%
2018-12-31โ‚น30.24 B12.52%
2017-12-31โ‚น26.88 B-17.71%
2016-12-31โ‚น32.66 B-0.13%
2015-12-31โ‚น32.71 B27.34%
2014-12-31โ‚น25.68 B-20.72%
2013-12-31โ‚น32.39 B31.27%
2012-12-31โ‚น24.68 B14.15%
2011-12-31โ‚น21.62 B12.07%
2010-12-31โ‚น19.29 B-12.12%
2009-12-31โ‚น21.95 B23.32%
2008-12-31โ‚น17.80 B-11.17%
2007-12-31โ‚น20.04 B-16.38%
2006-12-31โ‚น23.96 B0.16%
2005-12-31โ‚น23.92 B99.05%
2004-12-31โ‚น12.02 B-41.66%
2003-12-31โ‚น20.60 B7.46%
2002-12-31โ‚น19.17 B0.12%
2001-12-31โ‚น19.15 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚น10.949 T 61,642.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น11.296 T 63,594.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น7.624 T 42,890.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚น1.298 T 7,221.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น7.836 T 44,084.41%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น6.081 T 34,193.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚น4.02 B-77.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น62.13 B 250.36%๐Ÿ‡ฎ๐Ÿ‡ช Ireland